Beta-3 adrenergic receptor — Drug Target

All drugs that target Beta-3 adrenergic receptor — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

beta3-Adrenergic Agonist [EPC] · beta-3 adrenergic receptor agonist

Marketed (1)

• Myrbetriq · Apgdi · beta3-Adrenergic Agonist [EPC] · Urology
  Myrbetriq works by activating the beta-3 adrenergic receptor in the bladder muscle, leading to relaxation and improved bladder control.

Phase 3 pipeline (1)

• amibegron (SR58611A) · Sanofi · beta-3 adrenergic receptor agonist · Urology
  Amibegron is a beta-3 adrenergic receptor agonist.